(720 ILCS 570/204) (from Ch. 56 1/2, par. 1204)
Sec. 204. (a) The controlled substances listed in this Section are included in Schedule I.
(b) Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation:
(1) Acetylmethadol;
(1.1) Acetyl-alpha-methylfentanyl
(N-[1-(1-methyl-2-phenethyl)-
4-piperidinyl]-N-phenylacetamide);
(2) Allylprodine;
(3)
Alphacetylmethadol,
except
levo-alphacetylmethadol
(also
known
as
levo-alpha-
acetylmethadol,
levomethadyl
acetate,
or
LAAM);
(4) Alphameprodine;
(5) Alphamethadol;
(6)
Alpha-methylfentanyl
(N-(1-alpha-methyl-beta-phenyl)
ethyl-4-piperidyl)
propionanilide;
1-(1-methyl-2-phenylethyl)-4-(N-
propanilido)
piperidine;
(6.1)
Alpha-methylthiofentanyl
(N-[1-methyl-2-(2-thienyl)ethyl-
4-piperidinyl]-N-phenylpropanamide);
(7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
(7.1)
PEPAP
(1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
(8) Benzethidine;
(9) Betacetylmethadol;
(9.1)
Beta-hydroxyfentanyl
(N-[1-(2-hydroxy-2-phenethyl)-
4-piperidinyl]-N-phenylpropanamide);
(10) Betameprodine;
(11) Betamethadol;
(12) Betaprodine;
(13) Clonitazene;
(14) Dextromoramide;
(15) Diampromide;
(16) Diethylthiambutene;
(17) Difenoxin;
(18) Dimenoxadol;
(19) Dimepheptanol;
(20) Dimethylthiambutene;
(21) Dioxaphetylbutyrate;
(22) Dipipanone;
(23) Ethylmethylthiambutene;
(24) Etonitazene;
(25) Etoxeridine;
(26) Furethidine;
(27) Hydroxpethidine;
(28) Ketobemidone;
(29) Levomoramide;
(30) Levophenacylmorphan;
(31)
3-Methylfentanyl
(N-[3-methyl-1-(2-phenylethyl)-
4-piperidyl]-N-phenylpropanamide);
(31.1)
3-Methylthiofentanyl
(N-[(3-methyl-1-(2-thienyl)ethyl-
4-piperidinyl]-N-phenylpropanamide);
(32) Morpheridine;
(33) Noracymethadol;
(34) Norlevorphanol;
(35) Normethadone;
(36) Norpipanone;
(36.1)
Para-fluorofentanyl
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
4-piperidinyl]propanamide);
(37) Phenadoxone;
(38) Phenampromide;
(39) Phenomorphan;
(40) Phenoperidine;
(41) Piritramide;
(42) Proheptazine;
(43) Properidine;
(44) Propiram;
(45) Racemoramide;
(45.1)
Thiofentanyl
(N-phenyl-N-[1-(2-thienyl)ethyl-
4-piperidinyl]-propanamide);
(46) Tilidine;
(47) Trimeperidine;
(48)
Beta-hydroxy-3-methylfentanyl
(other
name:
N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
N-phenylpropanamide).
(c) Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers and salts of isomers, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) Acetorphine;
(2) Acetyldihydrocodeine;
(3) Benzylmorphine;
(4) Codeine methylbromide;
(5) Codeine-N-Oxide;
(6) Cyprenorphine;
(7) Desomorphine;
(8) Diacetyldihydromorphine (Dihydroheroin);
(9) Dihydromorphine;
(10) Drotebanol;
(11) Etorphine (except hydrochloride salt);
(12) Heroin;
(13) Hydromorphinol;
(14) Methyldesorphine;
(15) Methyldihydromorphine;
(16) Morphine methylbromide;
(17) Morphine methylsulfonate;
(18) Morphine-N-Oxide;
(19) Myrophine;
(20) Nicocodeine;
(21) Nicomorphine;
(22) Normorphine;
(23) Pholcodine;
(24) Thebacon.
(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for the purposes of this paragraph only, the term "isomer" includes the optical, position and geometric isomers):
(1)
3,4-methylenedioxyamphetamine
(alpha-methyl,3,4-methylenedioxyphenethylamine,
methylenedioxyamphetamine,
MDA);
(1.1)
Alpha-ethyltryptamine
(some
trade
or
other
names:
etryptamine;
MONASE;
alpha-ethyl-1H-indole-3-ethanamine;
3-(2-aminobutyl)indole;
a-ET;
and
AET);
(2) 3,4-methylenedioxymethamphetamine (MDMA);
(2.1)
3,4-methylenedioxy-N-ethylamphetamine
(also
known
as:
N-ethyl-alpha-methyl-
3,4(methylenedioxy)
Phenethylamine,
N-ethyl
MDA,
MDE,
and
MDEA);
(2.2) N-Benzylpiperazine (BZP);
(3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
(4) 3,4,5-trimethoxyamphetamine (TMA);
(5) (Blank);
(6) Diethyltryptamine (DET);
(7) Dimethyltryptamine (DMT);
(7.1) 5-Methoxy-diallyltryptamine;
(8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
(9)
Ibogaine
(some
trade
and
other
names:
7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
6,9-methano-5H-pyrido
[1',2':1,2]
azepino
[5,4-b]
indole;
Tabernanthe
iboga);
(10) Lysergic acid diethylamide;
(10.1) Salvinorin A;
(10.5) Salvia divinorum (meaning all parts of the
plant presently classified botanically as Salvia divinorum, whether growing or not, the seeds thereof, any extract from any part of that plant, and every compound, manufacture, salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, derivative, mixture, or preparation of that plant, its seeds or extracts);
(11) 3,4,5-trimethoxyphenethylamine (Mescaline);
(12) Peyote (meaning all parts of the plant presently
classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of that plant, and every compound, manufacture, salts, derivative, mixture, or preparation of that plant, its seeds or extracts);
(13) N-ethyl-3-piperidyl benzilate (JB 318);
(14) N-methyl-3-piperidyl benzilate;
(14.1)
N-hydroxy-3,4-methylenedioxyamphetamine
(also
known
as
N-hydroxy-alpha-methyl-
3,4(methylenedioxy)phenethylamine
and
N-hydroxy
MDA);
(15)
Parahexyl;
some
trade
or
other
names:
3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
dibenzo
(b,d)
pyran;
Synhexyl;
(16) Psilocybin;
(17) Psilocyn;
(18) Alpha-methyltryptamine (AMT);
(19)
2,5-dimethoxyamphetamine
(2,5-dimethoxy-alpha-methylphenethylamine;
2,5-DMA);
(20)
4-bromo-2,5-dimethoxyamphetamine
(4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
4-bromo-2,5-DMA);
(20.1)
4-Bromo-2,5
dimethoxyphenethylamine.
Some
trade
or
other
names:
2-(4-bromo-
2,5-dimethoxyphenyl)-1-aminoethane;
alpha-desmethyl
DOB,
2CB,
Nexus;
(21)
4-methoxyamphetamine
(4-methoxy-alpha-methylphenethylamine;
paramethoxyamphetamine;
PMA);
(22) (Blank);
(23)
Ethylamine
analog
of
phencyclidine.
Some
trade
or
other
names:
N-ethyl-1-phenylcyclohexylamine,
(1-phenylcyclohexyl)
ethylamine,
N-(1-phenylcyclohexyl)
ethylamine,
cyclohexamine,
PCE;
(24) Pyrrolidine analog of phencyclidine. Some trade
or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy, PHP;
(25) 5-methoxy-3,4-methylenedioxy-amphetamine;
(26)
2,5-dimethoxy-4-ethylamphetamine
(another
name:
DOET);
(27)
1-[1-(2-thienyl)cyclohexyl]
pyrrolidine
(another
name:
TCPy);
(28) (Blank);
(29)
Thiophene
analog
of
phencyclidine
(some
trade
or
other
names:
1-[1-(2-thienyl)-cyclohexyl]-piperidine;
2-thienyl
analog
of
phencyclidine;
TPCP;
TCP);
(30)
Bufotenine
(some
trade
or
other
names:
3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)-5-indolol;
5-hydroxy-N,N-dimethyltryptamine;
N,N-dimethylserotonin;
mappine);
(31)
1-Pentyl-3-(1-naphthoyl)indole
Some
trade
or
other
names:
JWH-018;
(32)
1-Butyl-3-(1-naphthoyl)indole
Some
trade
or
other
names:
JWH-073;
(33)
1-[(5-fluoropentyl)-1H-indol-3-yl]-
(2-iodophenyl)methanone
Some
trade
or
other
names:
AM-694;
(34)
2-[(1R,3S)-3-hydroxycyclohexyl]-5-
(2-methyloctan-2-yl)phenol
Some
trade
or
other
names:
CP
47,497
and
its
C6,
C8
and
C9
homologs;
(34.5)
2-[(1R,3S)-3-hydroxycyclohexyl]-5-
(2-methyloctan-2-yl)phenol),
where
side
chain
n=5;
and
homologues
where
side
chain
n=4,
6,
or
7;
Some
trade
or
other
names:
CP
47,497;
(35)
(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
(2-methyloctan-2-yl)-6a,7,
10,10a-tetrahydrobenzo[c]chromen-1-ol
Some
trade
or
other
names:
HU-210;
(35.5)
(6aS,10aS)-9-(hydroxymethyl)-6,6-
dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-
tetrahydrobenzo[c]chromen-1-ol,
its
isomers,
salts,
and
salts
of
isomers;
Some
trade
or
other
names:
HU-210,
Dexanabinol;
(36)
Dexanabinol,
(6aS,10aS)-9-(hydroxymethyl)-
6,6-dimethyl-3-(2-methyloctan-2-yl)-
6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
Some
trade
or
other
names:
HU-211;
(37)
(2-methyl-1-propyl-1H-indol-
3-yl)-1-naphthalenyl-methanone
Some
trade
or
other
names:
JWH-015;
(38)
4-methoxynaphthalen-1-yl-
(1-pentylindol-3-yl)methanone
Some
trade
or
other
names:
JWH-081;
(39)
1-Pentyl-3-(4-methyl-1-naphthoyl)indole
Some
trade
or
other
names:
JWH-122;
(40)
2-(2-methylphenyl)-1-(1-pentyl-
1H-indol-3-yl)-ethanone
Some
trade
or
other
names:
JWH-251;
(41)
1-(2-cyclohexylethyl)-3-
(2-methoxyphenylacetyl)indole
Some
trade
or
other
names:
RCS-8,
BTW-8
and
SR-18;
(42)
Any
compound
structurally
derived
from
3-(1-naphthoyl)indole
or
1H-indol-3-yl-
(1-naphthyl)methane
by
substitution
at
the
nitrogen
atom
of
the
indole
ring
by
alkyl,
haloalkyl,
alkenyl,
cycloalkylmethyl,
cycloalkylethyl
or
2-(4-morpholinyl)ethyl
whether
or
not
further
substituted
in
the
indole
ring
to
any
extent,
whether
or
not
substituted
in
the
naphthyl
ring
to
any
extent;
(43)
Any
compound
structurally
derived
from
3-(1-naphthoyl)pyrrole
by
substitution
at
the
nitrogen
atom
of
the
pyrrole
ring
by
alkyl,
haloalkyl,
alkenyl,
cycloalkylmethyl,
cycloalkylethyl
or
2-(4-morpholinyl)ethyl,
whether
or
not
further
substituted
in
the
pyrrole
ring
to
any
extent,
whether
or
not
substituted
in
the
naphthyl
ring
to
any
extent;
(44)
Any
compound
structurally
derived
from
1-(1-naphthylmethyl)indene
by
substitution
at
the
3-position
of
the
indene
ring
by
alkyl,
haloalkyl,
alkenyl,
cycloalkylmethyl,
cycloalkylethyl
or
2-(4-morpholinyl)ethyl
whether
or
not
further
substituted
in
the
indene
ring
to
any
extent,
whether
or
not
substituted
in
the
naphthyl
ring
to
any
extent;
(45)
Any
compound
structurally
derived
from
3-phenylacetylindole
by
substitution
at
the
nitrogen
atom
of
the
indole
ring
with
alkyl,
haloalkyl,
alkenyl,
cycloalkylmethyl,
cycloalkylethyl
or
2-(4-morpholinyl)ethyl,
whether
or
not
further
substituted
in
the
indole
ring
to
any
extent,
whether
or
not
substituted
in
the
phenyl
ring
to
any
extent;
(46)
Any
compound
structurally
derived
from
2-(3-hydroxycyclohexyl)phenol
by
substitution
at
the
5-position
of
the
phenolic
ring
by
alkyl,
haloalkyl,
alkenyl,
cycloalkylmethyl,
cycloalkylethyl
or
2-(4-morpholinyl)ethyl,
whether
or
not
substituted
in
the
cyclohexyl
ring
to
any
extent;
(47)
3,4-Methylenedioxymethcathinone
Some
trade
or
other
names:
Methylone;
(48)
3,4-Methyenedioxypyrovalerone
Some
trade
or
other
names:
MDPV;
(49)
4-Methylmethcathinone
Some
trade
or
other
names:
Mephedrone;
(50)
4-methoxymethcathinone;
(51)
4-Fluoromethcathinone;
(52)
3-Fluoromethcathinone;
(53)
2,5-Dimethoxy-4-(n)-propylthio-
phenethylamine;
(54)
5-Methoxy-N,N-diisopropyltryptamine;
(55)
Pentedrone;
(56)
4-iodo-2,5-dimethoxy-N-((2-methoxy
phenyl)methyl)-benzeneethanamine
(trade
or
other
name:
25I-NBOMe);
(57)
4-chloro-2,5-dimethoxy-N-[(2-methoxyphenyl)
methyl]-benzeneethanamine
(trade
or
other
name:
25C-NBOMe);
(58)
4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)
methyl]-benzeneethanamine
(trade
or
other
name:
25B-NBOMe).
(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) mecloqualone;
(2) methaqualone; and
(3) gamma hydroxybutyric acid.
(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
(1) Fenethylline;
(2) N-ethylamphetamine;
(3)
Aminorex
(some
other
names:
2-amino-5-phenyl-2-oxazoline;
aminoxaphen;
4-5-dihydro-5-phenyl-2-oxazolamine)
and
its
salts,
optical
isomers,
and
salts
of
optical
isomers;
(4)
Methcathinone
(some
other
names:
2-methylamino-1-phenylpropan-1-one;
Ephedrone;
2-(methylamino)-propiophenone;
alpha-(methylamino)propiophenone;
N-methylcathinone;
methycathinone;
Monomethylpropion;
UR
1431)
and
its
salts,
optical
isomers,
and
salts
of
optical
isomers;
(5)
Cathinone
(some
trade
or
other
names:
2-aminopropiophenone;
alpha-aminopropiophenone;
2-amino-1-phenyl-propanone;
norephedrone);
(6)
N,N-dimethylamphetamine
(also
known
as:
N,N-alpha-trimethyl-benzeneethanamine;
N,N-alpha-trimethylphenethylamine);
(7)
(+
or
-)
cis-4-methylaminorex
((+
or
-)
cis-
4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine);
(8) 3,4-Methylenedioxypyrovalerone (MDPV).
(g) Temporary listing of substances subject to emergency scheduling. Any material, compound, mixture, or preparation that contains any quantity of the following substances:
(1)
N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
(benzylfentanyl),
its
optical
isomers,
isomers,
salts,
and
salts
of
isomers;
(2)
N-[1(2-thienyl)
methyl-4-piperidyl]-N-phenylpropanamide
(thenylfentanyl),
its
optical
isomers,
salts,
and
salts
of
isomers.
(Source: P.A. 97-192, eff. 7-22-11; 97-193, eff. 1-1-12; 97-194, eff. 7-22-11; 97-334, eff. 1-1-12; 97-813, eff. 7-13-12; 97-872, eff. 7-31-12; 98-987, eff. 1-1-15.)
Sections: Previous 201 202 203 204 205 206 207 208 209 210 211 212 213 214 Next
Last modified: February 18, 2015